David Heber is the Director of the UCLA Center for Human Nutrition at the University of California, Los Angeles, a Professor of Medicine and Public Health, the founding Chief of the Division of Clinical Nutrition in the Department of Medicine and the Founding Director of the UCLA Center for Human Nutrition at UCLA. He directed the NCI-funded Clinical Nutrition Research Unit and the NIH Nutrition and Obesity Training Grants at UCLA from 1991 to 2006 and hasd conducted numerous government-funded research projects. Dr. Heber is board-certified in Internal Medicine, and Endocrinology and Metabolism by the American Board of Internal Medicine and in Clinical Nutrition by the American Board of Nutrition. He earned his MD at Harvard Medical School and his Ph.D. in Physiology at the University of California, Los Angeles. Dr. Heber served as a Director of the American Board of Nutrition and past chair of the Education Committee of the American Society of Clinical Nutrition. He is included in the 2011-2012 listing of The Best Doctors in America, based on a survey of over 35,000 doctors throughout the nation, and is listed in Who's Who in America for 2001. Dr. Heber's primary areas of research are obesity treatment and prevention, the role of nutrition, phytochemicals,and botanical dietary supplements in the prevention and treatment of common forms of cancer and cardiovascular disease. He is the author of over 200 peer-reviewed scientific articles, 50 book chapters, and two professional texts: Dietary Fat, Lipids, Hormones and Tumorigenesis and Nutritional Oncology (Academic Press, 1999, 2nd edition in preparation for 2005). Dr. Heber has also written four books for the public: Natural Remedies for a Healthy Heart (Avery Publishing Group 1998), The Resolution Diet (Avery Publishing Group 1999), What Color is Your Diet? (Harper Collins/Regan Books 2001), and The L.A. Shape Diet (Harper Collins/Regan Books March 2004).
Lu QY, Arteaga JR, Zhang Q, Huerta S, Go VL, Heber D Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances The Journal of nutritional biochemistry. , 2005; 16(1): 23-30.
Sartippour MR, Seeram NP, Heber D, Hardy M, Norris A, Lu Q, Zhang L, Lu M, Rao JY, Brooks MN Rabdosia rubescens inhibits breast cancer growth and angiogenesis International journal of oncology. , 2005; 26(1): 121-7.
Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, Li FP, Rao JY Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro Cancer letters. , 2004; 216(1): 9-20.
Seeram NP, Lee R, Heber D Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice Clinica chimica acta; international journal of clinical chemistry. , 2004; 348(1-2): 63-8.
Marks LS, Kojima M, Demarzo A, Heber D, Bostwick DG, Qian J, Dorey FJ, Veltri RW, Mohler JL, Partin AW Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue Urology. , 2004; 64(4): 765-71.
Lu QY, Sartippour MR, Brooks MN, Zhang Q, Hardy M, Go VL, Li FP, Heber D Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro Oncology reports. , 2004; 12(3): 659-62.
Sartippour MR, Heber D, Henning S, Elashoff D, Elashoff R, Rubio R, Zhang L, Norris A, Brooks MN cDNA microarray analysis of endothelial cells in response to green tea reveals a suppressive phenotype International journal of oncology. , 2004; 25(1): 193-202.
Sartippour MR, Rao JY, Apple S, Wu D, Henning S, Wang H, Elashoff R, Rubio R, Heber D, Brooks MN A pilot clinical study of short-term isoflavone supplements in breast cancer patients Nutrition and cancer. , 2004; 49(1): 59-65.
Seeram NP, Adams LS, Hardy ML, Heber D Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines Journal of agricultural and food chemistry. , 2004; 52(9): 2512-7.
Ngo TH, Barnard RJ, Anton T, Tran C, Elashoff D, Heber D, Freedland SJ, Aronson WJ Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence Cancer research. , 2004; 64(4): 1252-4.
Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, Heber D Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial Journal of the National Cancer Institute. , 2003; 95(23): 1765-71.
Ikezoe T, Chen SS, Tong XJ, Heber D, Taguchi H, Koeffler HP Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells International journal of oncology. , 2003; 23(4): 1187-93.
Ikezoe T, Chen S, Saito T, Asou H, Kyo T, Tanosaki S, Heber D, Taguchi H, Koeffler HP PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells International journal of oncology. , 2003; 23(4): 1203-11.
Ngo TH, Barnard RJ, Cohen P, Freedland S, Tran C, deGregorio F, Elshimali YI, Heber D, Aronson WJ Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis Clinical cancer research : an official journal of the American Association for Cancer Research. , 2003; 9(7): 2734-43.
Huerta S, Irwin RW, Heber D, Go VL, Moatamed F, Huerta S, Ou C, Harris DM Intestinal polyp formation in the Apcmin mouse: effects of levels of dietary calcium and altered vitamin D homeostasis Digestive diseases and sciences. , 2003; 48(5): 870-6.
Huerta S, Harris DM, Jazirehi A, Bonavida B, Elashoff D, Livingston EH, Heber D Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis International journal of oncology. , 2003; 22(3): 663-70.
Does this profile need updating? Contact Us